# Implantation or Injectable Dosage Form New Animal Drugs; Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate
> **Food and Drug Administration** · Final rule. · Published 2012-01-27 · Effective 2012-01-27 · 77 FR 4227
## Document
- **Document number:** 2012-1754
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 4227
- **CFR reference:** 21 CFR 522
- **Publication date:** 2012-01-27
- **Effective date:** 2012-01-27
- **HHS docket:** Docket No. FDA-2011-N-0003
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA extends the slaughter interval for intact male swine injected with gonadotropin releasing factor analog-diphtheria toxoid conjugate injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/01/27/2012-1754/implantation-or-injectable-dosage-form-new-animal-drugs-gonadotropin-releasing-factor)
---
*AI Analytics · CC0 1.0*